SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-083669
Filing Date
2013-11-12
Accepted
2013-11-12 16:46:25
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-19488_110q.htm 10-Q 791689
2 EX-31.1 a13-19488_1ex31d1.htm EX-31.1 14685
3 EX-31.2 a13-19488_1ex31d2.htm EX-31.2 14672
4 EX-32.1 a13-19488_1ex32d1.htm EX-32.1 4502
5 EX-32.2 a13-19488_1ex32d2.htm EX-32.2 4519
  Complete submission text file 0001104659-13-083669.txt   6797225

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgyp-20130930.xml EX-101.INS 720325
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20130930.xsd EX-101.SCH 100784
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20130930_cal.xml EX-101.CAL 53976
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20130930_def.xml EX-101.DEF 404013
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgyp-20130930_lab.xml EX-101.LAB 1274588
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20130930_pre.xml EX-101.PRE 580695
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 131210939
SIC: 2834 Pharmaceutical Preparations